Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History EVGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics EVGN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Evogene

EVGN
Current price
1.45 USD -0.01 USD (-0.68%)
Last closed 1.49 USD
ISIN IL0011050551
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 12 062 761 USD
Yield for 12 month -77.13 %
1Y
3Y
5Y
10Y
15Y
EVGN
21.11.2021 - 28.11.2021

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.50 USD

P/E Ratio

Dividend Yield

Financials EVGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures EVGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+8 511 000 USD

Last Year

+5 640 000 USD

Current Quarter

+2 444 000 USD

Last Quarter

+1 611 000 USD

Current Year

+5 828 000 USD

Last Year

+1 399 000 USD

Current Quarter

+830 000 USD

Last Quarter

+856 000 USD
EBITDA -21 154 000 USD
Operating Margin TTM -168.82 %
Price to Earnings
Return On Assets TTM -35.10 %
PEG Ratio
Return On Equity TTM -91.05 %
Wall Street Target Price 3.50 USD
Revenue TTM 6 765 000 USD
Book Value -0.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -41.70 %
Dividend Yield
Gross Profit TTM 2 778 000 USD
Earnings per share -2.51 USD
Diluted Eps TTM -2.51 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -224.82 %

Stock Valuation EVGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.17
Price Sales TTM 1.78
Enterprise Value EBITDA -0.81
Price Book MRQ 4.71

Technical Indicators EVGN

For 52 Weeks

0.95 USD 6.80 USD
50 Day MA 1.27 USD
Shares Short Prior Month 117 904
200 Day MA 1.63 USD
Short Ratio 0.10
Shares Short 495 673
Short Percent 7.44 %